The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial

Why are there no approved treatments for cognitive impairment in schizophrenia?

(2019) Richard S.E. Keefe   World Psychiatry

Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults

(2018) M.A. Van Duinen et al.   NEUROPHARMACOLOGY

Neural mechanisms of mismatch negativity dysfunction in schizophrenia

(2017) M Lee et al.   MOLECULAR PSYCHIATRY

Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial

(2017) Pim R. A. Heckman et al.   PSYCHOPHARMACOLOGY

The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses

(2016) Tim Vanmierlo et al.   BEHAVIOURAL BRAIN RESEARCH

A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression

(2016) Molly A. Erickson et al.   BIOLOGICAL PSYCHIATRY

Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications

(2016) Pim R. A. Heckman et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The 40-Hz Auditory Steady-State Response in Patients With Schizophrenia

(2016) Hanna Thuné et al.   JAMA Psychiatry

Intracranial recordings and human memory

(2015) Elizabeth L Johnson et al.   CURRENT OPINION IN NEUROBIOLOGY

Early Decision-Making in Drug Development: The Potential Role of Pharmaco-EEG and Pharmaco-Sleep

(2015) Frederick J. Wilson et al.   NEUROPSYCHOBIOLOGY

Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlates in COGS-2

(2015) Gregory A. Light et al.   SCHIZOPHRENIA RESEARCH

Frontal midline theta connectivity is related to efficiency of WM maintenance and is affected by aging

(2014) Brigitta Tóth et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Frontal theta as a mechanism for cognitive control

(2014) James F. Cavanagh et al.   TRENDS IN COGNITIVE SCIENCES

Frontal midline theta oscillations during working memory maintenance and episodic encoding and retrieval

(2013) Liang-Tien Hsieh et al.   NEUROIMAGE

A Novel Method for Reducing the Effect of Tonic Muscle Activity on the Gamma Band of the Scalp EEG

(2012) Judith F. Nottage et al.   BRAIN TOPOGRAPHY

Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement

(2012) Ali Hosseini-Sharifabad et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Characterization of Neurophysiologic and Neurocognitive Biomarkers for Use in Genomic and Clinical Outcome Studies of Schizophrenia

(2012) Gregory A. Light et al.   PLoS One

PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis

(2012) V Wiescholleck et al.   Translational Psychiatry

Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex

(2011) Mahomi Kuroiwa et al.   PSYCHOPHARMACOLOGY

Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associations

(2010) Daniel F. Hermens et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study

(2010) Robert S. Kern et al.   SCHIZOPHRENIA RESEARCH

The use of baseline covariates in crossover studies

(2009) Michael G. Kenward et al.   BIOSTATISTICS

Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400

(2009) Connie C. Duncan et al.   CLINICAL NEUROPHYSIOLOGY

Control mechanisms in working memory: A possible function of EEG theta oscillations

(2009) Paul Sauseng et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle

(2008) T. B. Halene et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Subjective and objective quality of life in schizophrenia

(2007) Jenille M. Narvaez et al.   SCHIZOPHRENIA RESEARCH